07:16 AM EST, 02/10/2025 (MT Newswires) -- Roivant Sciences ( ROIV ) reported fiscal Q3 earnings Monday of $0.23 per diluted share, down from $6.03 a year earlier.

Four analysts polled by FactSet expected a loss of $0.31.

Revenue for the quarter ended Dec. 31 was $9 million, compared with $15.6 million a year earlier.

Analysts surveyed by FactSet expected $5 million.